Co-Authors
This is a "connection" page, showing publications co-authored by Elizabeth Phillips and Kimberly Blumenthal.
Connection Strength
1.861
-
Antibiotic allergy. Lancet. 2019 01 12; 393(10167):183-198.
Score: 0.800
-
Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose. JAMA Intern Med. 2021 11 01; 181(11):1530-1533.
Score: 0.244
-
COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach. J Allergy Clin Immunol Pract. 2021 06; 9(6):2135-2138.
Score: 0.235
-
Reply to "PEG skin testing for COVID-19 allergy". J Allergy Clin Immunol Pract. 2021 04; 9(4):1765-1766.
Score: 0.234
-
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach. J Allergy Clin Immunol Pract. 2021 04; 9(4):1423-1437.
Score: 0.230
-
Reply to "How important is the second dose of the COVID-19 mRNA vaccine?" J Allergy Clin Immunol Pract. 2021 06; 9(6):2537-2539.
Score: 0.059
-
The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis. J Allergy Clin Immunol Pract. 2021 07; 9(7):2556-2561.
Score: 0.059